DR info

Clinical trials : 13 / Drugs : 21 - (DrugBank : 11) / Drug target genes : 11 - Drug target pathways : 103

Ehlers-Danlos syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
168	Ehlers-Danlos syndrome
96	Crohn disease
113	Muscular dystrophy
46	Malignant rheumatoid arthritis
58	Hypertrophic cardiomyopathy
193	Prader-Willi syndrome
86	Pulmonary arterial hypertension
127	Frontotemporal lobar degeneration
36	Epidermolysis bullosa
107	Juvenile idiopathic arthritis
226	Interstitial cystitis with Hunners ulcer
70	Spinal stenosis
28	Systemic amyloidosis
51	Scleroderma
97	Ulcerative colitis
2	Amyotrophic lateral sclerosis
6	Parkinson disease
13	Multiple sclerosis/Neuromyelitis optica
1	Spinal and bulbar muscular atrophy
10	Charcot-Marie-Tooth disease
38	Stevens-Johnson syndrome
114	Non-dystrophic myotonia syndrome
256	Muscle glycogenosis
231	Alpha-1-antitrypsin deficiency
140	Dorabe syndrome
144	Lennox-Gastaut syndrome
298	Hereditary pancreatitis
53	Sjogren syndrome
156	Rett syndrome
84	Sarcoidosis
8	Huntington disease
34	Neurofibromatosis
299	Cystic fibrosis
232	Carney complex
191	Werner syndrome